APA (7th ed.) Citation

BC, Y., YS, K., Hi, K., SH, K., SS, P., YR, S., . . . BS, K. (2012). A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C. Clinical and molecular hepatology, 18(3), 272. https://doi.org/10.3350/cmh.2012.18.3.272

Chicago Style (17th ed.) Citation

BC, You, et al. "A Reduced Dose of Ribavirin Does Not Influence the Virologic Response During Pegylated Interferon Alpha-2b and Ribavirin Combination Therapy in Patients with Genotype 1 Chronic Hepatitis C." Clinical and Molecular Hepatology 18, no. 3 (2012): 272. https://doi.org/10.3350/cmh.2012.18.3.272.

MLA (9th ed.) Citation

BC, You, et al. "A Reduced Dose of Ribavirin Does Not Influence the Virologic Response During Pegylated Interferon Alpha-2b and Ribavirin Combination Therapy in Patients with Genotype 1 Chronic Hepatitis C." Clinical and Molecular Hepatology, vol. 18, no. 3, 2012, p. 272, https://doi.org/10.3350/cmh.2012.18.3.272.